{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:56:37Z","timestamp":1791942997139,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007263","name":"Virginia Polytechnic Institute and State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.micpath.2022.105454","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T21:03:08Z","timestamp":1645218188000},"page":"105454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1730-4150","authenticated-orcid":false,"given":"Nader S.","family":"Abutaleb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-4327","authenticated-orcid":false,"given":"Ahmed E.M.","family":"Elhassanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2022.105454_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01225-19","article-title":"Repurposing salicylamide for combating multidrug-resistant Neisseria gonorrhoeae","volume":"63","author":"Alhashimi","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2022.105454_bib3","series-title":"Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria Gonorrhoeae","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.micpath.2022.105454_bib4","series-title":"Antibiotic Resistance Threats in the United States","year":"2019"},{"key":"10.1016\/j.micpath.2022.105454_bib5","series-title":"Antibiotic Resistance Threats in the United States","year":"2013"},{"key":"10.1016\/j.micpath.2022.105454_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria gonorrhoeae: drug resistance, mouse models, and vaccine development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2022.105454_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CMR.17.4.965-981.2004","article-title":"The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women","volume":"17","author":"Edwards","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2022.105454_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajem.2011.07.014","article-title":"Laboratory-confirmed gonorrhea and\/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis","volume":"30","author":"Burnett","year":"2012","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.micpath.2022.105454_bib9","first-page":"139","article-title":"Gonorrhea: update","volume":"101","author":"Little","year":"2006","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.micpath.2022.105454_bib10","series-title":"Emergence of Multi-Drug Resistant Neisseria Gonorrhoeae \u2013Threat of Global Rise in Untreatable Sexually Transmitted Infections","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.micpath.2022.105454_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1651-2227.1987.tb10451.x","article-title":"Etiology and diagnosis of neonatal conjunctivitis","volume":"76","author":"Sandstrom","year":"1987","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.micpath.2022.105454_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0049-0172(81)80002-9","article-title":"Disseminated gonococcal infection (DGI) and gonococcal arthritis (GCA): II. Clinical manifestations, diagnosis, complications, treatment, and prevention","volume":"10","author":"Masi","year":"1981","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.micpath.2022.105454_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.EI10-0009-2015","article-title":"Antimicrobial resistance expressed by Neisseria gonorrhoeae: a major global public health problem in the 21st century","volume":"4","author":"Unemo","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"69","key":"10.1016\/j.micpath.2022.105454_bib14","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC's treatment guidelines for gonococcal infection","volume":"2020","author":"St Cyr","year":"2020","journal-title":"Mmwr-Morbid. Mortal. Week. Rep."},{"key":"10.1016\/j.micpath.2022.105454_bib15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2022.105454_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.micpath.2022.105454_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2022.105454_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/CVI.00230-16","article-title":"Summary and recommendations from the national Institute of allergy and infectious diseases (NIAID) workshop \"gonorrhea vaccines: the way forward","volume":"23","author":"Wetzler","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2022.105454_bib19","series-title":"Diiodohydroxyquinoline for the Treatment of clostridium Difficile Infection","author":"Seleem","year":"2021"},{"key":"10.1016\/j.micpath.2022.105454_bib20","first-page":"11","article-title":"In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection","author":"Abutaleb","year":"2021","journal-title":"Sci. Rep.-Uk"},{"key":"10.1016\/j.micpath.2022.105454_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01715-20","article-title":"In vivo antibacterial activity of acetazolamide","volume":"65","author":"Abutaleb","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2022.105454_bib22","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11059","article-title":"In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci","volume":"9","author":"Abutaleb","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.micpath.2022.105454_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02115-19","article-title":"Repurposing the antiamoebic drug diiodohydroxyquinoline for treatment of clostridioides difficile infections","volume":"64","author":"Abutaleb","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2022.105454_bib24","article-title":"Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection","volume":"10","author":"Abutaleb","year":"2020","journal-title":"Sci. Rep.-Uk"},{"key":"10.1016\/j.micpath.2022.105454_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.009","article-title":"Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies","volume":"55","author":"Abutaleb","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2022.105454_bib26","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1038\/s41598-021-90360-x","article-title":"Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs","volume":"11","author":"Mohammad","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2022.105454_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247508","article-title":"Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice","volume":"16","author":"Mohammad","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2022.105454_bib28","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1038\/s41598-020-64352-2","article-title":"Auranofin rapidly eradicates methicillin-resistant Staphylococcus aureus (MRSA) in an infected pressure ulcer mouse model","volume":"10","author":"Mohammad","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2022.105454_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ijantimicag.2018.02.003","article-title":"Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci","volume":"51","author":"Mohammad","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2022.105454_bib30","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acsinfecdis.1c00055","article-title":"Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae","volume":"7","author":"Hewitt","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105454_bib31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1517\/14728222.2015.1067685","article-title":"Bacterial, fungal and protozoan carbonic anhydrases as drug targets","volume":"19","author":"Capasso","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.micpath.2022.105454_bib32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543776.2020.1811853","article-title":"Antibacterial carbonic anhydrase inhibitors: an update on the recent literature","volume":"30","author":"Supuran","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.micpath.2022.105454_bib33","doi-asserted-by":"crossref","first-page":"10579","DOI":"10.1093\/nar\/gku762","article-title":"Transcriptional landscape and essential genes of Neisseria gonorrhoeae","volume":"42","author":"Remmele","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2022.105454_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.629163","article-title":"Carbonic anhydrases: new perspectives on protein functional role and inhibition in Helicobacter pylori","volume":"12","author":"Campestre","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2022.105454_bib35","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/14756366.2020.1800670","article-title":"Escherichia coli gamma-carbonic anhydrase: characterisation and effects of simple aromatic\/heterocyclic sulphonamide inhibitors","volume":"35","author":"Del Prete","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.micpath.2022.105454_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205153","article-title":"Mycobacterium tuberculosis beta-carbonic anhydrases: novel targets for developing antituberculosis drugs","volume":"20","author":"Aspatwar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2022.105454_bib37","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/IAI.67.11.5699-5708.1999","article-title":"Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice","volume":"67","author":"Jerse","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2022.105454_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2011.00107","article-title":"Estradiol-treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections","volume":"2","author":"Jerse","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2022.105454_bib39","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1016\/j.vaccine.2008.08.020","article-title":"Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice","volume":"26","author":"Song","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2022.105454_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-4939-9496-0_24","article-title":"Female mouse model of Neisseria gonorrhoeae infection","volume":"1997","author":"Raterman","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.micpath.2022.105454_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijantimicag.2016.06.009","article-title":"Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo","volume":"48","author":"Schmitt","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2022.105454_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/j.1552-4604.1998.tb05791.x","article-title":"Pharmacokinetics of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude","volume":"38","author":"Ritschel","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.micpath.2022.105454_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s002280050422","article-title":"Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation","volume":"54","author":"Yano","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.micpath.2022.105454_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WNO.0000000000000322","article-title":"Safety and tolerability of acetazolamide in the idiopathic intracranial hypertension treatment trial","volume":"36","author":"ten Hove","year":"2016","journal-title":"J. Neuro Ophthalmol."},{"key":"10.1016\/j.micpath.2022.105454_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/iai.32.1.105-110.1981","article-title":"Gonococcal infection in endotoxin-resistant and endotoxin-susceptible mice","volume":"32","author":"Streeter","year":"1981","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2022.105454_bib46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijantimicag.2016.06.009","article-title":"Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo","volume":"48","author":"Schmitt","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2022.105454_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01644-18","article-title":"Pharmacokinetic data are predictive of in vivo efficacy for cefixime and ceftriaxone against susceptible and resistant Neisseria gonorrhoeae strains in the gonorrhea mouse model","volume":"63","author":"Connolly","year":"2019","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:51:15Z","timestamp":1760111475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401022000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"alternative-id":["S0882401022000675"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105454","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105454"}}